3644 results for «2900»
3644 results
TAVI in heart failure is possible
21 May 2026 – From EuroPCR 2026
This session demonstrates the feasibility of transcatheter aortic valve implantation (TAVI) in patients with heart failure through a series of challenging cases. It covers sequential management of hypertrophic obstructive cardiomyopathy with aortic stenosis, advanced heart failure interventions, staged approaches in cardiogenic shock, and complex percutaneous interventions...
Refining management of NSTEMI
21 May 2026 – From EuroPCR 2026
This session refines NSTEMI management by exploring advanced diagnostic tools, risk stratification, and tailored revascularization strategies, including bleeding risk assessment and dual antiplatelet therapy considerations.
Interventions for heart failure: shock and beyond
20 May 2026 – From EuroPCR 2026
Focused on interventions for heart failure, this session presents data on mitral regurgitation post-alcohol septal ablation, outcomes from high-risk PCI supported by Impella CP, evolving trends in ECMO utilization for cardiogenic shock, and six-month patient outcomes guided by shock team management strategies.
Complications in CAD PCI
20 May 2026 – From EuroPCR 2026
This session focuses on the recognition and management of complications during coronary artery disease PCI. It includes cases of acute guide catheter crises, rare post-PCI chest pain etiologies, innovative stent retrieval techniques, and critical procedural challenges, providing an educational journey through complex complication management.
Redo TAVI challenges
20 May 2026 – From EuroPCR 2026
Focused on the complexities of redo transcatheter aortic valve implantation (TAVI), this session covers innovative techniques such as jailed-balloon to prevent sinus sequestration, CT-guided emergency valve-in-valve procedures, alternative access routes, and strategies to manage coronary occlusion risks during multiple valve interventions.
Combination of dedicated devices for optimal treatment of calcified lesions
20 May 2026 – From EuroPCR 2026
Focused on the optimal treatment of heavily calcified coronary lesions, this session presents a comprehensive overview of dedicated device combinations. It highlights strategies such as rotablation, rotatripsy, and approaches to managing protruding calcified nodules and undilatable lesions, emphasizing a stepwise approach to complex calcium modification in...
Stentless PCI, DCB and BVS in complex scenarios
20 May 2026 – From EuroPCR 2026
This session explores the use of stentless percutaneous coronary interventions (PCI) employing drug-coated balloons (DCB) and bioresorbable scaffolds (BVS) in complex coronary scenarios. Through detailed case discussions, it addresses decision-making processes, technical considerations, and practical tips for successfully completing PCI without permanent stenting.
PCI in cardiogenic shock - Possibilities and limitations
20 May 2026 – From EuroPCR 2026
This session evaluates percutaneous coronary intervention (PCI) in the context of cardiogenic shock, discussing both possibilities and limitations. It features complex cases including Impella-supported rotablation in elderly patients, microaxial flow pump use, and challenging interventions in young patients with multivessel chronic total occlusions, providing insights into...
How to safely perform a retrograde CTO PCI: step-by-step guidance
20 May 2026 – From EuroPCR 2026
This session offers step-by-step guidance on safely performing retrograde chronic total occlusion (CTO) percutaneous coronary intervention (PCI). It covers the fundamentals of retrograde setup and collateral crossing, execution of a controlled reverse CART technique, and addresses common pitfalls with practical tips to improve procedural success and...
New evidence for coronary physiology in epicardial disease
20 May 2026 – From EuroPCR 2026
Explore new evidence in coronary physiology related to epicardial disease through analyses of landmark trials and registries. Topics include five-year follow-up data from DEFINE-FLAIR and iFR-SWEDEHEART, complete revascularization in elderly myocardial infarction patients, angiography-derived versus pressure wire assessments, prognostic implications of CT angiography-derived physiology, and the...
TAV-in-SAV TAVI procedure - LIVE case
21 May 2026 – From EuroPCR 2026
A 70‑year‑old man with COPD and a history of severe aortic stenosis treated with SAVR (27 mm Perimount Magna) in 2012, followed by endocarditis in 2013, presented with symptomatic degeneration of the surgical valve, predominantly as severe aortic regurgitation. Left ventricular function was preserved (LVEF 50%)...
AsiaPCR/SingLIVE 2017: Opening Ceremony
19 Jan 2017 – From AsiaPCR/SingLIVE 2017
Consult the Opening ceremony of the AsiaPCR/SingLIVE 2017 course edition, the Chien Foundation Award for outstanding lectureship and lifetime achievement in PCI is awarded to Prof. A. Seth.
Chairperson
Challenging scenarios in STEMI patients
14 Apr 2021 – From EuroPCR 2021
In this session, you'll discover challenging STEMI cases: STEMI with cardiogenic shock and no vascular access for mechanical support, anterior STEMI with critical LMCA stenosis, double culprits STEMI, and much more!
Challenging cases in difficult clinical scenarios
14 Apr 2021 – From EuroPCR 2021
Thanks to this session, you will know more about how to manage simultaneous myocardial infarction and arm ischemia, how to facilitate antegrade wiring of tortuous RCA thanks to sub-intimal dissection and stabilisation, how to guide the way when handling a difficult graft PCI, and more!
HIGHLIFE transseptal mitral valve replacement (TSMVR): clinical study update
18 May 2021 – From EuroPCR 2021
Watch this session presented by Didier Tchetche in order to learn about the HighLife transseptal mitral valve replacement study status, to understand the complex patient population treated and first outcomes, and to be familiar with the current technology and future enhancements.
Complex PCI with short DAPT: the trade-off between ischaemia and bleeding
18 May 2021 – From EuroPCR 2021
Watch this session presented by Benjamin Faurie, Roxana Mehran and Manel Sabate in order to understand the trade-off between ischaemic risk and bleeding risk, to hear about the results of LM-PCI with Biofreedom Ultra and short DAPT, and to learn how to use short DAPT in patients undergoing complex...
XLIMIT - Randomised controlled trial to assess endothelisation of Xlimus DES
18 May 2021 – From EuroPCR 2021
Watch this session presented by Luca Testa in order to know about XLIMIT randomised clinical trial, and to learn about Xlimus DES stent with Sirolimus and bioabsorbable polymer coating.
The uncompromised hemodynamics of the ALLEGRA transfemoral TAVI system in native and small annuli
18 May 2021 – From EuroPCR 2021
Watch this session presented by Raul Moreno and Dave Smith in order to learn about the hemodynamic performance of the ALLEGRA TAVI system, to share the experience of European centres through challenging ALLEGRA cases, and to focus on the outcome of the ALLEGRA TAVI system in small annuli...
Short DAPT in high bleeding risk: ready for prime time?
20 May 2021 – From EuroPCR 2021
Watch this session presented by Roxana Mehran, Davide Capodanno, Pieter Smits and Marco Valgimigli in order to discuss integrated framework for the decision making on DAPT duration in high bleeding risk patients, to understand the implications of the available evidence and gaps in knowledge, and to learn...
Diffuse Coronary Artery Disease: RESTORE DCB – THE HYPER STUDY
18 May 2021 – From EuroPCR 2021
Watch this session presented by Alfonso Lelasi in order to have an update on the treatment of diffuse CAD involving small vessels and/or bifurcation with a novel hybrid (DES and DCB) approach, to understand the rationale of The HYPER Study (NCT03939468), and to know more about third generation RESTORE...
